key: cord-0876408-59d21ffh
authors: Storino, Colleen B.; Watson, James C.; Sanchez, William; Brown, Michael J.; Tande, Aaron J.; Loftus, Conor G.
title: Mayo Clinic Strategies for COVID-19: Revamping Outpatient Care for Patients Without COVID-19
date: 2020-06-20
journal: Mayo Clin Proc
DOI: 10.1016/j.mayocp.2020.06.010
sha: 94e2bb3e563086f8149d439dc9b05bad96437989
doc_id: 876408
cord_uid: 59d21ffh

nan

Mayo Clinic's integrated multidisciplinary destination outpatient practices deliver care daily to thousands of unique patients, which has required substantial changes in care delivery during the coronavirus disease 2019 (COVID-19) pandemic to ensure the safety of patients and employees. On the Rochester campus of Mayo Clinic, for example, over 9,000 unique patients with complex medical conditions visit a concentrated campus, occupying less than 0.01 square mile, every day. The combination of patients, their accompanying visitors, and Mayo Clinic staff results in a medical campus with a population density an order of magnitude larger than the most population-dense US city. To protect the safety of patients and staff, Mayo Clinic decided to defer elective outpatient clinic visits as well as elective surgeries and procedures on all of its campuses as part of its initial response to the COVID-19 pandemic. Early on, the clinical practice recognized the urgency of caring for patients who need Mayo Clinic the most and rapidly transformed processes, policies, and protocols to provide safe care in the COVID-19 environment that is in the best interests of patients, staff, and communities served.

Mayo Clinic is now focused on reactivating its clinical practice while nimbly navigating unprecedented conditions. Reforecasting of practice volumes and patient demand; effectively communicating to patients, staff, referring providers, visitors, and our communities; and implementing safety initiatives are key components of reactivation. To effectively scale and time operational adjustments, these changes must occur in parallel with nontraditional limiting factors such as molecular and serologic testing capacity, availability of critical pharmaceuticals and personal protective equipment, and reduced personnel as a result of staffing-to-workload interventions.

Successful outpatient practice reactivation has been based in part on the structured deactivation. As the practice was deactivated, providers reviewed all scheduled appointments to define medical urgency and determine whether a virtual evaluation could be substituted for the original in-person appointment. Patients with urgent medical conditions continued to have in-person care (eg, oncology-related outpatient practices continued at 65% or more of normal), but appointments were converted to virtual evaluations when possible. Patient-initiated cancellations were also reviewed to prioritize rescheduling based on medical necessity. As we began reaching out to patients to reschedule, scripting and workflows were modified to include 1) an explanation of why we had paused routine outpatient care and the new safety protocols, 2) telephone screening for COVID-19 and a protocol to define when a patient who had positive test results could safely be rescheduled in the regular practice, and 3) a process to reassess patients for COVID-19 by telephone 12 to 48 hours before an inperson visit. We developed dashboards that allowed monitoring of our in-person outpatient practice and procedural reactivation. Safety and modeling resources helped practices struggling to reactivate high-throughput clinics with the inefficiencies inherent in COVID-19 safety protocols. Daily touchpoints with scheduling office supervisors and the outpatient leadership team allowed us to keep an accurate pulse of scheduling challenges and maintain alignment with the latest COVID-19 institutional modeling.

Finally, we developed models of demand capture that allowed us to be strategic in where we prioritized offering appointments.

The initial rapid contraction of the outpatient practice and subsequent, staged reactivation required substantial operational agility and planning. Initial response efforts focused on assessing urgency of individual patient appointments and contacting patients to defer appointments for nonurgent or elective care. Over 38,000 appointments were deferred during the first week of the response, more than 6 times the normal rescheduling rate. Nonessential operations staff were released to home or redeployed to new COVID-19 response activities, such as screening patients and visitors. Operations management staff assessed novel training needs to prepare for practice reactivation and developed training modules and scripts for use by scheduling, screening, and patient-arrival staff. Reporting tools were developed to monitor demand and identify and track deferred appointments so that patients could be contacted during the reactivation phase. The medical staff continued to monitor new and deferred appointment requests during the contraction period to identify medically urgent requests, and the outpatient practice functioned at 30% of its normal capacity before the practice was reactivated-most of that care delivered via virtual/telemedicine mechanisms. Because of the highly integrated nature of Mayo Clinic, outpatient leadership worked in concert with surgical and hospital leadership to maintain a cohesive approach to reactivation of outpatient activities. Operations began reactivation efforts in earnest during the week of April 20, 2020-4 weeks after the initial contraction of the practice.

As Mayo Clinic moved to reactivate the practice, we sought to optimize safety by utilizing infrastructure developed over the preceding weeks of the initial pandemic response. We had developed a well-functioning algorithm nurses used to screen symptomatic patients by telephone for COVID-19 diagnostic testing. This algorithm was revised to allow employees at Mayo Clinic entrances to identify symptomatic patients upon arrival. Along with this, we developed workflows to quickly divert symptomatic patients to COVID-19 testing, temporarily pausing their clinical itinerary while results of diagnostic testing were pending. An important strength during this time was a robust laboratory capacity for molecular diagnostic and serologic testing. Reports in the medical literature suggested that many infected persons were asymptomatic or presymptomatic. 1 Therefore, we developed protocols for testing and interpreting results for asymptomatic patients before they received certain types of care. For example, asymptomatic patients who were undergoing surgical procedures or beginning immunosuppressive therapy were tested to avoid a potentially poor outcome resulting from an unrecognized COVID-19 infection. 2 In addition, we began testing asymptomatic patients before procedures that would confer additional exposure risk to employees participating in those procedures.

To connect with patients during a period of widespread travel restrictions, Mayo Clinic embraced telemedicine. The Centers for Medicare & Medicaid Services and other payors facilitated telemedicine use by granting substantial latitude for providing virtual visits. 3 Before the COVID-19 crisis, telemedicine use was limited, most commonly to postoperative or other follow-up visits. During the weeks before practice reactivation, telemedicine visits increased 33-fold while in-person visits decreased in parallel. During reactivation, in-person visits have increased with a commensurate decrease in telemedicine visits, although an important role remains for the ongoing use of telemedicine. In particular, telemedicine intake visits provide a rapid point of first contact with patients who have serious and complex illnesses. These intake visits allow a member of the patient's health care team to identify concerns, obtain important external records, and create an optimized and condensed itinerary that can reduce the amount of time a patient needs to remain on a Mayo Clinic campus for testing and treatment.

Multiple departments and divisions recognize the benefit of ongoing telemedicine visits as part of the care continuum. Rather than developing multiple divergent workflows, Mayo Clinic outpatient practice leadership is working to incorporate telemedicine offerings in a systematic rather than piecemeal fashion.

As Mayo Clinic reactivated the outpatient practice, clear communications were needed to inform patients, visitors, and health care team members of the changes.

Once safety interventions were in place, Mayo Clinic began reaching out to let patients know that outpatient services were being gradually expanded. Multiple methods were used to communicate this information, including Patient Online Services, mailed letters, and direct telephone calls. We worked closely with care team members to assure them that it was safe to reactivate the outpatient practice after a careful review of safety measures within the internal work environment and analysis of risk from the external environment, which showed signs of stabilizing (eg, increased viral doubling times and evidence of flattening of the curve). Additional internal safety measures were introduced and rationales communicated, including universal masking of patients, visitors, and health care workers; patient screening; social distancing; molecular testing for high-risk patients; and optimized facility management. A series of employee-focused virtual question/answer sessions were held, highlighting what had changed internally and externally to allow the practice to be safely reactivated.

Mayo Clinic's integrated multidisciplinary destination outpatient practice has been substantially impacted by the COVID-19 pandemic. Multiple changes have been made to optimize safety for patients, visitors, and care team members. The outpatient practice at Mayo Clinic has now been safely reactivated and will continue to evolve in the context of the COVID-19 pandemic.

Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility

Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine. 2020:100331

Additional background: sweeping regulatory changes to help U.S. healthcare system address COVID-19 patient surge

Editing, proofreading, and reference verification were provided by Scientific Publications, Mayo Clinic.